NMTR / 9 Meters Biopharma Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5

9 Meters Biopharma Inc
US ˙ NASDAQ ˙ US6544051096
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier15.953.350 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

9 Meters Biopharma Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NMTR / 9 Meters Biopharma Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-07-06 Temperato John 125.000 0,2277 6.250 4,5540 28.462 50 6.3 10.913 38,34
2022-07-01 Sirgo Mark A 175.000 0,2455 8.750 4,9100 42.962
2022-05-23 Constantino Michael T. 16.000 0,4755 800 9,5100 7.608
2022-05-18 Sirgo Mark A 106.383 0,4700 5.319 9,4000 50.000
2022-05-18 Temperato John 50.000 0,4457 2.500 8,9140 22.285
2022-03-03 Temperato John 100.000 0,5559 5.000 11,1180 55.590
2022-03-03 Sirgo Mark A 86.450 0,5784 4.322 11,5680 50.002
2021-12-02 Sirgo Mark A 50.000 0,8900 2.500 17,8000 44.500
2021-11-18 Sirgo Mark A 20.000 1,0600 1.000 21,2000 21.200

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NMTR / 9 Meters Biopharma Inc Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NMTR / 9 Meters Biopharma Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-04-21 Sensenig Bethany 9.100 1,2100 9.100 1,2100 11.011 95 0.0722 -10.354 -94,03
2021-06-25 OrbiMed Israel GP Ltd. 15.989.876 1,2100 799.494 24,2000 19.347.750
2021-06-24 OrbiMed Israel GP Ltd. 319.255 1,3800 15.963 27,6000 440.572
2021-06-23 OrbiMed Israel GP Ltd. 841.650 1,3600 42.082 27,2000 1.144.644

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NMTR / 9 Meters Biopharma Inc Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2023-04-21 2023-04-21 4 Sensenig Bethany NMTR Common stock S - Sale D 1,2100 -9.100 -11 41.077
2023-03-31 2023-03-29 4 Sirgo Mark A NMTR Common Stock A - Award D 7.885 85.907
2023-03-31 2023-03-29 4 RICE YEHUDA MICHAEL NMTR Common Stock A - Award D 7.885 7.885
2023-03-31 2023-03-29 4 JOHNSON LORIN K NMTR Common Stock A - Award D 7.885 12.125
2023-03-31 2023-03-29 4 Constantino Michael T. NMTR Common Stock A - Award D 7.885 10.911
2023-03-31 2023-03-29 4 Ventimiglia Samantha NMTR Common Stock A - Award D 7.885 7.885
2023-03-29 2023-03-27 4 Temperato John NMTR Common Stock A - Award D 68.815 140.192
2023-03-29 2023-03-27 4 Sensenig Bethany NMTR Common Stock A - Award D 50.177 50.177
2022-07-22 2022-07-01 4/A Sirgo Mark A NMTR Common stock A - Award D 0,2455 175.000 43 1.560.428
2022-07-08 2022-07-06 4 Temperato John NMTR Common stock P - Purchase D 0,2277 125.000 28 1.427.522
2022-07-06 2022-07-01 4 Sirgo Mark A NMTR Common stock P - Purchase D 0,2455 175.000 43 1.454.045
2022-05-24 2022-05-23 4 Constantino Michael T. NMTR Common Stock P - Purchase D 0,4755 16.000 8 60.509
2022-05-19 2022-05-18 4 Temperato John NMTR Common Stock P - Purchase D 0,4457 50.000 22 1.302.522
2022-05-19 2022-05-18 4 Sirgo Mark A NMTR Common Stock P - Purchase D 0,4700 106.383 50 1.385.428
2022-03-21 2020-08-20 4/A Constantino Michael T. NMTR Common stock P - Purchase D 0,7545 26.509 20 26.509
2022-03-07 2022-03-03 4 Sirgo Mark A NMTR Common stock P - Purchase D 0,5784 86.450 50 1.279.045
2022-03-04 2022-03-03 4 Temperato John NMTR Common stock P - Purchase D 0,5559 100.000 56 1.252.522
2022-02-23 2022-02-21 4 Temperato John NMTR Stock Option (Right to Buy) A - Award D 0,65 2.479.060 2.479.060
2022-01-18 2022-01-18 4 Sensenig Bethany NMTR Stock Option (Right to Buy) A - Award D 0,84 1.300.000 1.300.000
2021-12-03 2021-12-02 4 Sirgo Mark A NMTR Common Stock P - Purchase D 0,8900 50.000 44 1.242.595
2021-11-22 2021-11-18 4 Sirgo Mark A NMTR Common stock P - Purchase D 1,0600 20.000 21 1.192.595
2021-11-19 2021-11-18 4 Temperato John NMTR Common stock P - Purchase D 1,0500 50.000 52 1.152.522
2021-10-04 2021-10-01 4 Ventimiglia Samantha NMTR Stock Option (Right to Buy) A - Award D 1,29 1,2900 150.000 194 150.000
2021-09-15 2021-09-14 4 Sitar Edward J NMTR Common stock P - Purchase D 1,2200 15.000 18 194.338
2021-09-08 2021-09-07 4 Sirgo Mark A NMTR Common stock P - Purchase D 1,3600 73.529 100 1.172.595
2021-08-26 2021-08-24 4 Constantino Michael T. NMTR Common stock P - Purchase D 1,1400 18.000 21 52.108
2021-08-23 2021-08-20 4 Sirgo Mark A NMTR Common stock P - Purchase D 1,1000 25.000 28 1.099.066
2021-08-19 2021-08-18 4 Temperato John NMTR Common stock P - Purchase D 1,0500 25.000 26 1.102.522
2021-06-25 2021-06-25 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Common Stock S - Sale I 1,2100 -15.989.876 -19.348 8.565.974
2021-06-25 2021-06-24 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Common Stock S - Sale I 1,3800 -319.255 -441 24.555.850
2021-06-25 2021-06-23 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Common Stock S - Sale I 1,3600 -841.650 -1.145 24.875.105
2021-06-23 2021-06-22 4 JOHNSON LORIN K NMTR Stock Option (Right to Buy) A - Award D 1,38 90.000 90.000
2021-06-23 2021-06-22 4 Sirgo Mark A NMTR Stock Option (Right to Buy) A - Award D 1,38 90.000 90.000
2021-06-23 2021-06-22 4 Constantino Michael T. NMTR Stock Option (Right to Buy) A - Award D 1,38 90.000 90.000
2021-05-13 2021-05-11 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Stock Option (right to buy) X - Other I 0,62 19.444 80.556
2021-05-13 2021-05-11 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Stock Option (right to buy) X - Other I 0,70 12.500 37.500
2021-05-13 2021-05-11 4 OrbiMed Israel GP Ltd. See Footnotes (1)(2 NMTR Common Stock X - Other I 0,6216 19.444 12 25.748.699
2021-05-13 2021-05-11 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Common Stock X - Other I 0,7000 12.500 9 25.729.255
2021-04-06 2021-04-05 4 Sirgo Mark A NMTR Common stock P - Purchase D 1,0000 300.000 300 1.074.066
2021-04-06 2021-04-05 4 Temperato John NMTR Common stock P - Purchase D 1,0000 100.000 100 1.077.522
2021-04-06 2021-04-05 4 Sitar Edward J NMTR Common stock P - Purchase D 1,0000 50.000 50 179.338
2021-03-19 2020-05-04 4/A OrbiMed Israel GP Ltd. See Footnotes NMTR Series A Convertible Preferred Stock P - Purchase I 67.865 6.786.500
2021-03-19 2020-05-04 4/A OrbiMed Israel GP Ltd. See Footnotes NMTR Series A Convertible Preferred Stock P - Purchase I 67.865 6.786.500
2021-03-19 2020-04-30 4/A OrbiMed Israel GP Ltd. See Footnotes NMTR Common Stock A - Award I 18.930.255 18.930.255
2021-03-02 2021-02-26 4 RICE YEHUDA MICHAEL NMTR Stock Option (Right to Buy) A - Award D 1,66 150.000 150.000
2021-02-05 2021-02-04 4 Temperato John NMTR Stock Option (Right to Buy) A - Award D 1,81 1.309.626 1.309.626
2021-02-05 2021-02-04 4 Sitar Edward J NMTR Stock Option (Right to Buy) A - Award D 1,81 477.468 477.468
2020-12-17 2020-12-15 4 Sirgo Mark A NMTR Common stock P - Purchase D 0,6500 230.769 150 774.066
2020-12-17 2020-12-15 4 Temperato John NMTR Common stock P - Purchase D 0,6500 153.846 100 977.522
2020-12-17 2020-12-15 4 Sitar Edward J NMTR Common stock P - Purchase D 0,6500 61.538 40 129.338
2020-12-01 2020-11-27 4 Temperato John NMTR Stock Option (Right to Buy) J - Other D 1,07 639.655 639.655
2020-12-01 2020-11-27 4 Temperato John NMTR Stock Option (Right to Buy) J - Other D 1,07 650.000 650.000
2020-12-01 2020-11-27 4 Temperato John NMTR Stock Option (Right to Buy) J - Other D 0,62 -639.655 310.345
2020-12-01 2020-11-27 4 Temperato John NMTR Stock Option (Right to Buy) J - Other D 0,62 -650.000 0
2020-12-01 2020-11-27 4 Temperato John NMTR Common stock A - Award D 203.667 823.676
2020-11-03 2020-10-30 4 OrbiMed Israel GP Ltd. NMTR Common stock J - Other I 1.943.734 25.716.755
2020-11-03 2020-10-30 4 Sirgo Mark A NMTR Common stock J - Other D 4.513 543.297
2020-11-03 2020-10-30 4 Darvish Nissim NMTR Common stock J - Other I 1.943.734 25.716.755
2020-11-03 2020-10-30 4 Temperato John NMTR Common stock J - Other D 4.513 620.009
2020-09-14 2020-09-11 4 Sirgo Mark A by spouse NMTR Common stock P - Purchase I 0,6518 21.485 14 21.485
2020-09-14 2020-09-11 4 Sirgo Mark A NMTR Common stock P - Purchase D 0,6800 77.000 52 538.784
2020-09-14 2020-09-10 4 Sirgo Mark A NMTR Common stock P - Purchase D 0,6000 50.000 30 461.784
2020-08-24 2020-08-21 4 Temperato John NMTR Common stock P - Purchase D 0,6900 70.000 48 615.496
2020-08-21 2020-08-20 4 Constantino Michael T. NMTR Common stock P - Purchase D 0,7500 34.108 26 34.108
2020-08-18 2020-08-17 4 Sirgo Mark A NMTR Common stock P - Purchase D 0,5600 100.000 56 411.784
2020-08-17 2020-08-17 4 Temperato John NMTR Common stock P - Purchase D 0,5666 35.000 20 545.496
2020-07-08 2020-07-06 4 Constantino Michael T. NMTR Stock Option (Right to Buy) A - Award D 0,62 150.000 150.000
2020-07-08 2020-07-06 4 Darvish Nissim NMTR Stock Option (Right to Buy) A - Award I 0,62 100.000 100.000
2020-07-08 2020-07-06 4 Sitar Edward J NMTR Stock Option (Right to Buy) A - Award D 0,62 225.000 775.000
2020-07-08 2020-07-06 4 Sitar Edward J NMTR Stock Option (Right to Buy) A - Award D 0,62 550.000 550.000
2020-07-08 2020-07-06 4 JOHNSON LORIN K NMTR Stock Option (Right to Buy) A - Award D 0,62 150.000 150.000
2020-07-08 2020-07-06 4 Laumas Sandeep NMTR Stock Option (Right to Buy) A - Award D 0,62 150.000 150.000
2020-07-08 2020-07-06 4 Sirgo Mark A NMTR Stock Option (Right to Buy) A - Award D 0,62 100.000 100.000
2020-07-08 2020-07-06 4 Temperato John NMTR Stock Option (Right to Buy) A - Award D 0,62 650.000 1.600.000
2020-07-08 2020-07-06 4 Temperato John NMTR Stock Option (Right to Buy) A - Award D 0,62 950.000 950.000
2020-07-02 2020-06-30 4 Darvish Nissim NMTR Series A Convertible Preferred Stock C - Conversion I -67.865 0
2020-07-02 2020-06-30 4 Darvish Nissim See footnote 1 NMTR Common stock C - Conversion I 6.786.500 23.773.021
2020-07-02 2020-06-30 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Series A Convertible Preferred Stock C - Conversion I -67.865 0
2020-07-02 2020-06-30 4 OrbiMed Israel GP Ltd. NMTR Common stock C - Conversion I 6.786.500 23.773.021
2020-07-02 2020-06-30 4 Sitar Edward J NMTR Series A Convertible Preferred Stock C - Conversion D -678 0
2020-07-02 2020-06-30 4 Sitar Edward J NMTR Common stock C - Conversion D 67.800 67.800
2020-07-02 2020-06-30 4 Laumas Sandeep NMTR Series A Convertible Preferred Stock C - Conversion D -424 0
2020-07-02 2020-06-30 4 Laumas Sandeep NMTR Common stock C - Conversion D 42.400 60.400
2020-07-02 2020-06-30 4 Temperato John NMTR Series A Convertible Preferred Stock C - Conversion D -2.714 0
2020-07-02 2020-06-30 4 Temperato John NMTR Common stock C - Conversion D 271.400 510.496
2020-07-02 2020-06-30 4 JOHNSON LORIN K NMTR Series A Convertible Preferred Stock C - Conversion D -848 0
2020-07-02 2020-06-30 4 JOHNSON LORIN K NMTR Common stock C - Conversion D 84.800 84.800
2020-07-02 2020-06-30 4 Sirgo Mark A NMTR Series A Convertible Preferred Stock C - Conversion D -2.544 0
2020-07-02 2020-06-30 4 Sirgo Mark A NMTR Common stock C - Conversion D 254.400 311.784
2020-07-01 2020-06-30 4 Temperato John NMTR Common stock A - Award D 189.655 239.096
2020-06-16 2020-06-15 4 Sirgo Mark A NMTR Common stock P - Purchase D 0,5975 17.943 11 57.384
2020-06-15 2020-06-15 4 Temperato John NMTR Common stock P - Purchase D 0,5971 10.000 6 49.441
2020-05-05 2020-05-04 4 Darvish Nissim NMTR Series A Convertible Preferred Warrant P - Purchase I 67.865 6.786.500
2020-05-05 2020-05-04 4 Darvish Nissim NMTR Series A Convertible Preferred Stock P - Purchase I 67.865 6.786.500
2020-05-05 2020-05-04 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Series A Convertible Preferred Warrant P - Purchase I 67.865 6.786.500
2020-05-05 2020-05-04 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Series A Convertible Preferred Stock P - Purchase I 67.865 6.786.500
2020-05-04 2020-04-30 4 Temperato John NMTR Stock Option (Right to Buy) A - Award D 0,70 1.000.000 1.000.000
2020-05-04 2020-05-04 4 Temperato John NMTR Series A Convertible Preferred Warrant P - Purchase D 2.714 271.400
2020-05-04 2020-05-04 4 Temperato John NMTR Series A Convertible Preferred Stock P - Purchase D 2.714 271.400
2020-05-04 3 OrbiMed Israel BioFund GP Limited Partnership NMTR Common stock I 33.973.042
2020-05-04 3 OrbiMed Israel BioFund GP Limited Partnership NMTR Common stock I 33.973.042
2020-05-04 3 OrbiMed Israel BioFund GP Limited Partnership NMTR Common stock I 33.973.042
2020-05-04 3 OrbiMed Israel BioFund GP Limited Partnership NMTR Common stock I 33.973.042
2020-05-04 2020-04-30 4 Sirgo Mark A NMTR Stock Option (Right to Buy) A - Award D 0,70 50.000 50.000
2020-05-04 2020-05-04 4 Sirgo Mark A NMTR Series A Convertible Preferred Warrant P - Purchase D 2.544 254.400
2020-05-04 2020-05-04 4 Sirgo Mark A NMTR Series A Convertible Preferred Stock P - Purchase D 2.544 254.400
2020-05-04 2020-04-30 4 OrbiMed Israel GP Ltd. See Footnotes NMTR Stock Option (Right to Buy) A - Award I 0,70 50.000 50.000
2020-05-04 3 Darvish Nissim See footnote 1 NMTR Common stock I 33.973.042
2020-05-04 3 Darvish Nissim See footnote 1 NMTR Common stock I 33.973.042
2020-05-04 3 Darvish Nissim See footnote 1 NMTR Common stock I 33.973.042
2020-05-04 2020-04-30 4 Darvish Nissim NMTR Stock Option (Right to Buy) A - Award I 0,70 50.000 50.000
2020-05-04 3 Sirgo Mark A NMTR Common stock D 78.882
2020-05-04 3 Sirgo Mark A NMTR Common stock D 78.882
2020-05-04 3 Sirgo Mark A NMTR Common stock D 78.882
2020-05-04 3 Temperato John NMTR Common stock D 78.882
2020-05-04 3 Temperato John NMTR Common stock D 78.882
2020-05-04 3 Temperato John NMTR Common stock D 78.882
2020-05-04 2020-05-04 4 JOHNSON LORIN K NMTR Series A Convertible Preferred Warrant P - Purchase D 848 84.800
2020-05-04 2020-05-04 4 JOHNSON LORIN K NMTR Series A Convertible Preferred Stock P - Purchase D 848 84.800
2020-05-04 2020-05-04 4 Laumas Sandeep NMTR Series A Convertible Preferred Warrant P - Purchase D 424 42.400
2020-05-04 2020-05-04 4 Laumas Sandeep NMTR Series A Convertible Preferred Stock P - Purchase D 424 42.400
2020-05-04 2020-05-04 4 Sitar Edward J NMTR Series A Convertible Preferred Warrant P - Purchase D 678 67.800
2020-05-04 2020-05-04 4 Sitar Edward J NMTR Series A Convertible Preferred Stock P - Purchase D 678 67.800
2020-05-04 2020-04-24 4 Proujansky Roy NMTR Stock Option (Right to Buy) A - Award D 0,60 25.000 25.000
2020-05-04 2020-04-24 4 JOHNSON LORIN K NMTR Stock Option (Right to Buy) A - Award D 0,60 25.000 25.000
2020-05-04 2020-04-24 4 Laumas Sandeep NMTR Stock Option (Right to Buy) A - Award D 0,60 389.294 389.294
2020-05-04 2020-04-24 4 MAIDA ANTHONY E III NMTR Stock Option (Right to Buy) A - Award D 0,60 25.000 25.000
2020-05-04 2020-04-30 4 Sitar Edward J NMTR Stock Option (Right to Buy) A - Award D 0,70 125.000 125.000
2020-05-04 2020-04-24 4 Sitar Edward J NMTR Stock Option (Right to Buy) A - Award D 0,60 176.156 176.156
2020-05-04 2020-04-24 4 Madan Jay P. NMTR Stock Option (Right to Buy) A - Award D 0,60 203.406 203.406
2020-05-04 2020-04-24 4 Ramasastry Saira NMTR Stock Option (Right to Buy) A - Award D 0,60 25.000 25.000
2019-08-27 2019-08-20 4 Madan Jay P. INNT Stock Option (Right to Buy) A - Award D 0,89 200.000 200.000
2019-08-27 2019-08-20 4 Laumas Sandeep INNT Stock Option (Right to Buy) A - Award D 0,89 400.000 400.000
2019-07-03 2019-07-01 4 Sitar Edward J INNT Stock Option (Right to Buy) A - Award D 1,17 350.000 350.000
2019-07-01 2019-06-28 4 Laumas Sandeep INNT Common stock P - Purchase D 1,1500 4.000 5 18.000
2019-06-17 2019-06-13 4 Laumas Sandeep INNT Common stock P - Purchase D 1,2200 591 1 14.000
2019-06-17 2019-06-13 4 Laumas Sandeep INNT Common stock P - Purchase D 1,2100 409 0 13.409
2019-06-04 2019-05-31 4 JOHNSON LORIN K INNT Stock Option (Right to Buy) A - Award D 1,28 25.000 25.000
2019-06-04 2019-05-31 4 MAIDA ANTHONY E III INNT Stock Option (Right to Buy) A - Award D 1,28 25.000 25.000
2019-06-04 2019-05-31 4 Proujansky Roy INNT Stock Option (Right to Buy) A - Award D 1,28 25.000 25.000
2019-06-04 2019-05-31 4 Ramasastry Saira INNT Stock Option (Right to Buy) A - Award D 1,28 25.000 25.000
2019-06-03 2019-05-30 4 Madan Jay P. INNT Common stock P - Purchase D 1,3200 5.000 7 84.131
2019-05-28 2019-05-24 4 Proujansky Roy INNT Common stock P - Purchase D 1,2800 1.000 1 2.400
2019-05-23 2019-05-22 4 Laumas Sandeep INNT Common stock P - Purchase D 1,3800 5.000 7 13.000
2018-12-07 2018-12-04 4 Ramasastry Saira INNT Stock Option (Right to Buy) A - Award D 2,41 25.000 25.000
2018-12-07 2018-12-04 4 Ramasastry Saira INNT Stock Option (Right to Buy) A - Award D 6,94 50.000 50.000
2018-12-07 2018-12-04 4 Proujansky Roy INNT Stock Option (Right to Buy) A - Award D 2,41 25.000 25.000
2018-12-07 2018-12-04 4 Proujansky Roy INNT Stock Option (Right to Buy) A - Award D 6,94 50.000 50.000
2018-12-07 2018-12-04 4 JOHNSON LORIN K INNT Stock Option (Right to Buy) A - Award D 2,41 25.000 25.000
2018-12-07 2018-12-04 4 MAIDA ANTHONY E III INNT Stock Option (Right to Buy) A - Award D 2,41 25.000 25.000
2018-12-03 2018-11-30 4 Proujansky Roy INNT Common stock P - Purchase D 2,6300 1.400 4 1.400
2018-12-03 2018-11-30 4 Laumas Sandeep INNT Common stock P - Purchase D 2,6300 1.000 3 8.000
2018-12-03 2018-11-30 4 Laumas Sandeep INNT Common stock P - Purchase D 2,6200 1.000 3 7.000
2018-12-03 2018-11-30 4 Laumas Sandeep INNT Common stock P - Purchase D 2,6400 1.000 3 6.000
2018-11-29 2018-11-29 4 Prior Christopher P. INNT Common stock P - Purchase D 2,7500 5.000 14 7.009
2018-11-29 2018-11-29 4 Laumas Sandeep INNT Common stock P - Purchase D 2,5600 2.000 5 5.000
2018-11-29 2018-11-29 4 Laumas Sandeep INNT Common stock P - Purchase D 2,5500 1.000 3 3.000
2018-09-14 2018-09-14 4 Prior Christopher P. INNT Common stock P - Purchase D 5,8200 200 1 2.009
2018-09-13 2018-09-12 4 Prior Christopher P. INNT Common stock P - Purchase D 6,1300 500 3 1.809
2018-09-10 2018-09-07 4 Laumas Sandeep INNT Common stock P - Purchase D 6,1000 500 3 2.000
2018-08-30 2018-08-28 4/A Laumas Sandeep INNT Common stock P - Purchase D 4,9000 250 1 250
2018-08-30 2018-08-30 4 Prior Christopher P. INNT Common stock P - Purchase D 5,2000 309 2 1.309
2018-08-30 2018-08-30 4 Laumas Sandeep INNT Common stock P - Purchase D 5,2400 500 3 750
2018-08-28 2018-08-28 4 Laumas Sandeep INNT Common stock P - Purchase D 5,0800 405 2 1.000
2018-08-28 2018-08-28 4 Laumas Sandeep INNT Common stock P - Purchase D 5,0700 95 0 595
2018-08-28 2018-08-28 4 Laumas Sandeep INNT Common stock P - Purchase D 4,8800 250 1 500
2018-08-28 2018-08-28 4 Laumas Sandeep INNT Common stock P - Purchase D 4,9000 0 0 250
2018-08-28 2018-08-28 4 Prior Christopher P. INNT Common stock P - Purchase D 4,9300 1.000 5 1.000
2018-08-28 2018-08-27 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4,9400 100 0 900
2018-08-28 2018-08-27 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4,9600 253 1 800
2018-08-28 2018-08-27 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4,9000 47 0 547
2018-08-28 2018-08-24 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4,8500 500 2 1.400
2018-08-28 2018-08-24 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4,9900 400 2 500
2018-08-28 2018-08-24 4 Almenoff June Sherie By Meadowlark Management LLC INNT Common stock P - Purchase I 4,8500 100 0 100
2018-04-18 3 Sea Island Partnership LLC INNT Common Stock D 5.784.596
2018-04-18 3 Sea Island Partnership LLC INNT Common Stock D 5.784.596
2018-04-18 3 Sea Island Partnership LLC INNT Common Stock D 5.784.596
2018-04-18 3 Moonstar Family Partnership LLC INNT Common Stock D 5.376.434
2018-04-18 3 Moonstar Family Partnership LLC INNT Common Stock D 5.376.434
2018-04-18 3 Moonstar Family Partnership LLC INNT Common Stock D 5.376.434
2018-03-13 3 CLARKE DAVID H By GSB Holdings, Inc INNT Common Stock I 2.781.800
2018-03-13 3 CLARKE DAVID H INNT Common Stock D 2.373.550
2018-03-13 3 CLARKE DAVID H By GSB Holdings, Inc INNT Common Stock I 2.781.800
2018-03-13 3 CLARKE DAVID H INNT Common Stock D 2.373.550
2018-03-13 2018-01-25 4 CLARK JONATHAN P INNT Common Stock A - Award D 10.000 285.000
2018-03-13 2018-01-25 4 Olert David Lewis INNT Common Stock A - Award D 10.000 70.000
2018-03-13 2018-01-26 4 CLARKE DAVID H INNT Common Stock P - Purchase I 0,3500 300.000 105 1.718.450
2018-03-13 2018-01-25 4 CLARKE DAVID H INNT Common Stock A - Award D 25.000 1.418.450
2018-03-13 2018-01-24 4 CLARKE DAVID H INNT Common Stock A - Award I 17.746 1.393.450
2018-03-13 2017-11-29 4 CLARKE DAVID H INNT Common Stock P - Purchase I 0,4500 366.159 165 1.375.704
2018-03-13 2017-11-09 4 CLARKE DAVID H INNT Common Stock A - Award D 100.000 1.009.545
2018-03-13 2017-06-30 4 CLARKE DAVID H INNT Common Stock A - Award I 13.467 909.545
2018-03-13 2017-06-30 4 CLARKE DAVID H INNT Common Stock A - Award I 33.621 896.078
2018-03-13 2017-06-23 4 CLARKE DAVID H INNT Common Stock P - Purchase I 0,5800 172.414 100 862.457
2018-03-13 2017-03-16 4 CLARKE DAVID H INNT Common Stock P - Purchase I 1,5000 70.000 105 690.043
2018-03-13 2017-01-24 4 CLARKE DAVID H INNT Common Stock A - Award D 175.000 620.043
2018-03-13 2016-07-13 4 CLARKE DAVID H INNT Common Stock P - Purchase D 4,5000 15.000 68 445.043
2018-02-08 3 Laumas Sandeep INNT Common Stock I 1.516.746
2018-02-08 3 Laumas Sandeep INNT Common Stock I 1.516.746
2018-02-08 3 Madan Jay P. INNT Common Stock I 1.154.629
2018-02-08 3 Madan Jay P. INNT Common Stock I 1.147.140
2018-02-08 3 Madan Jay P. INNT Common Stock I 1.147.140
2018-02-08 3 Madan Jay P. INNT Common Stock D 1.554.167
2018-02-08 3 Madan Jay P. INNT Common Stock I 1.154.629
2018-02-08 3 Madan Jay P. INNT Common Stock I 1.147.140
2018-02-08 3 Madan Jay P. INNT Common Stock I 1.147.140
2018-02-08 3 Madan Jay P. INNT Common Stock D 1.554.167
2018-02-08 3 Madan Jay P. INNT Common Stock I 1.147.140
2018-02-08 3 Madan Jay P. INNT Common Stock I 1.147.140
2017-11-21 2017-11-09 4 BARRE STEVEN C MSDI Common Stock A - Award D 10.000 50.000
2017-11-21 2017-11-09 4 CLARK JONATHAN P MSDI Common Stock A - Award D 25.000 275.000
2017-11-21 2017-11-09 4 Olert David Lewis MSDI Common Stock A - Award D 10.000 60.000
2017-07-13 2017-05-08 4 Olert David Lewis MSDI Common Stock A - Award D 10.000 50.000
2017-07-13 2017-07-11 4 BARRE STEVEN C MSDI Common Stock A - Award D 10.000 40.000
2017-07-13 2017-05-31 4 BARRE STEVEN C MSDI Common Stock A - Award D 15.000 30.000
2017-07-13 2017-07-11 4 MACHINIST ROBERT MSDI Common Stock A - Award D 10.000 35.000
2017-07-13 2017-05-31 4 MACHINIST ROBERT MSDI Common Stock A - Award D 10.000 25.000
2017-07-13 2017-07-11 4 MINER CHRISTOPHER MICHAEL MSDI Common Stock A - Award D 10.000 35.000
2017-07-13 2017-05-31 4 MINER CHRISTOPHER MICHAEL MSDI Common Stock A - Award D 10.000 25.000
2017-02-10 3 BROWNSELL STEPHEN R MSDI Common Stock D 270.000
2017-02-10 3 BROWNSELL STEPHEN R MSDI Common Stock D 270.000
2017-01-27 2017-01-24 4 MACHINIST ROBERT MSDI Common Stock A - Award D 5.000 15.000
2017-01-26 2017-01-24 4 BARRE STEVEN C MSDI Common Stock A - Award D 5.000 15.000
2017-01-26 2017-01-24 4 MINER CHRISTOPHER MICHAEL MSDI Common Stock A - Award D 5.000 15.000
2017-01-26 2017-01-24 4 CLARK JONATHAN P MSDI Common Stock A - Award D 240.000 250.000
2017-01-25 2017-01-24 4 Olert David Lewis MSDI Common Stock A - Award D 15.000 40.000
2017-01-25 2017-01-24 4 MATEJKA MARC S MSDI Common Stock A - Award D 15.000 40.000
2016-11-18 2016-11-16 4 BARRE STEVEN C MSDI Common Stock A - Award D 10.000 10.000
2016-07-27 2016-07-07 4 CLARK JONATHAN P MSDI Common Stock A - Award D 10.000 10.000
2016-07-26 2016-07-07 4 Olert David Lewis MSDI Employee Stock Options (right to buy_ A - Award D 4,50 16.834 16.834
2016-07-26 2016-07-07 4 Olert David Lewis MSDI Common Stock A - Award D 25.000 25.000
2016-07-26 2016-07-07 4 TANDON VIVEK MSDI Employee Stock Options (right to buy) A - Award D 4,50 18.000 18.000
2016-07-26 2016-07-07 4 TANDON VIVEK MSDI Common Stock A - Award D 25.000 25.000
2016-07-26 2016-07-07 4 TANDON JAWAHAR See footnote 3. MSDI Warrants to Purchase Common Stock A - Award I 5,62 76.911 76.911
2016-07-26 2016-07-07 4 TANDON JAWAHAR MSDI Common Stock A - Award D 125.000 125.000
2016-07-20 2016-07-07 4 ORBAN JONATHAN S MSDI Common Stock A - Award D 10.000 10.000
2016-07-19 2016-07-07 4 MATEJKA MARC S MSDI Employee Stock Options (right to buy) A - Award D 4,50 18.000 18.000
2016-07-19 2016-07-07 4 MATEJKA MARC S MSDI Common Stock A - Award D 25.000 25.000
2016-07-13 2016-07-07 4 MACHINIST ROBERT MSDI Common Stock A - Award D 10.000 10.000
2016-07-13 2016-07-07 4 MINER CHRISTOPHER MICHAEL MSDI Common Stock A - Award D 10.000 10.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista